ATE444984T1 - Hydrolysestabile maleimidendgruppen-enthaltende polymere - Google Patents
Hydrolysestabile maleimidendgruppen-enthaltende polymereInfo
- Publication number
- ATE444984T1 ATE444984T1 AT03800391T AT03800391T ATE444984T1 AT E444984 T1 ATE444984 T1 AT E444984T1 AT 03800391 T AT03800391 T AT 03800391T AT 03800391 T AT03800391 T AT 03800391T AT E444984 T1 ATE444984 T1 AT E444984T1
- Authority
- AT
- Austria
- Prior art keywords
- hydrolysis
- end groups
- polymers containing
- containing maleimide
- stable polymers
- Prior art date
Links
- 229920000642 polymer Polymers 0.000 title abstract 2
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical group O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 title 1
- 239000002243 precursor Substances 0.000 abstract 1
- 229920003169 water-soluble polymer Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/333—Polymers modified by chemical after-treatment with organic compounds containing nitrogen
- C08G65/33396—Polymers modified by chemical after-treatment with organic compounds containing nitrogen having oxygen in addition to nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/30—Post-polymerisation treatment, e.g. recovery, purification, drying
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/333—Polymers modified by chemical after-treatment with organic compounds containing nitrogen
- C08G65/33331—Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing imide group
- C08G65/33337—Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing imide group cyclic
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2203/00—Applications
- C08L2203/02—Applications for biomedical use
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
- Polyethers (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43721102P | 2002-12-31 | 2002-12-31 | |
| PCT/US2003/041699 WO2004060965A2 (en) | 2002-12-31 | 2003-12-31 | Hydrolytically stable maleimide-terminated polymers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE444984T1 true ATE444984T1 (de) | 2009-10-15 |
Family
ID=32713147
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03800391T ATE444984T1 (de) | 2002-12-31 | 2003-12-31 | Hydrolysestabile maleimidendgruppen-enthaltende polymere |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7432330B2 (de) |
| EP (1) | EP1578842B1 (de) |
| JP (1) | JP4490290B2 (de) |
| KR (1) | KR101025143B1 (de) |
| CN (1) | CN100343304C (de) |
| AT (1) | ATE444984T1 (de) |
| AU (1) | AU2003300133B2 (de) |
| CA (1) | CA2509153C (de) |
| DE (1) | DE60329627D1 (de) |
| MX (1) | MXPA05007151A (de) |
| WO (1) | WO2004060965A2 (de) |
Families Citing this family (108)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7432331B2 (en) | 2002-12-31 | 2008-10-07 | Nektar Therapeutics Al, Corporation | Hydrolytically stable maleimide-terminated polymers |
| US7910661B2 (en) | 2003-01-06 | 2011-03-22 | Nektar Therapeutics | Thiol-selective water-soluble polymer derivatives |
| PL1656410T3 (pl) * | 2003-07-22 | 2010-08-31 | Nektar Therapeutics | Sposób wytwarzania sfunkcjonalizowanych polimerów z polimerycznych alkoholi |
| US7790835B2 (en) | 2003-12-03 | 2010-09-07 | Nektar Therapeutics | Method of preparing maleimide functionalized polymers |
| GB0329825D0 (en) * | 2003-12-23 | 2004-01-28 | Celltech R&D Ltd | Biological products |
| US6887952B1 (en) * | 2004-02-12 | 2005-05-03 | Biosite, Inc. | N-aryl-carbamic acid ester-derived and valeric acid ester-derived cross-linkers and conjugates, and methods for their synthesis and use |
| MXPA06010764A (es) * | 2004-03-23 | 2006-12-15 | Amgen Inc | Metodos y composiciones de proteinas quimicamente modificadas. |
| DK2371856T3 (en) | 2004-11-12 | 2022-08-08 | Bayer Healthcare Llc | Site-directed modifikation af FVIII |
| JP5243041B2 (ja) * | 2004-12-21 | 2013-07-24 | ネクター セラピューティックス | 安定化ポリマーチオール試薬 |
| JP4877225B2 (ja) * | 2005-02-18 | 2012-02-15 | 日油株式会社 | ポリオキシアルキレン誘導体 |
| US20060233740A1 (en) * | 2005-03-23 | 2006-10-19 | Bossard Mary J | Conjugates of an hGH moiety and a polymer |
| US8273339B2 (en) | 2005-04-12 | 2012-09-25 | Nektar Therapeutics | Polymer-based compositions and conjugates of antimicrobial agents |
| AU2006249144B2 (en) | 2005-05-18 | 2011-11-17 | Ablynx Nv | Improved NanobodiesTM against Tumor Necrosis Factor-alpha |
| EP1926768B1 (de) | 2005-07-18 | 2011-09-14 | Nektar Therapeutics | Verzweigte funktionalisierte polymere unter verwendung von verzweigten polyolen als kernen |
| CA2614987C (en) * | 2005-07-19 | 2013-10-08 | Nektar Therapeutics Al, Corporation | Method for preparing polymer maleimides |
| WO2007075534A2 (en) | 2005-12-16 | 2007-07-05 | Nektar Therapeutics Al, Corporation | Polymer conjugates of glp-1 |
| US7743730B2 (en) * | 2005-12-21 | 2010-06-29 | Lam Research Corporation | Apparatus for an optimized plasma chamber grounded electrode assembly |
| EP2319542B1 (de) | 2006-02-21 | 2018-03-21 | Nektar Therapeutics | Segmentierte abbaubare Polymere und daraus hergestellte Konjugate |
| US20070238163A1 (en) * | 2006-04-05 | 2007-10-11 | Golova Julia B | Covalent attachment of biomolecules to solid supports by a polymerization method |
| SI2084183T1 (sl) | 2006-10-13 | 2010-09-30 | Lilly Co Eli | Pegilirani pth kot modulatorji pth receptorja in njihove uporabe |
| DK2101821T3 (da) | 2006-12-15 | 2014-10-06 | Baxter Healthcare Sa | Faktor VIIA-(poly)sialinsyre-konjugat med forlænget halveringstid in vivo |
| US9156914B2 (en) | 2006-12-19 | 2015-10-13 | Ablynx N.V. | Amino acid sequences directed against a metalloproteinase from the ADAM family and polypeptides comprising the same for the treatment of ADAM-related diseases and disorders |
| AU2007336242B2 (en) | 2006-12-19 | 2012-08-30 | Ablynx N.V. | Amino acid sequences directed against GPCRs and polypeptides comprising the same for the treatment of GPCR-related diseases and disorders |
| WO2008088983A1 (en) * | 2007-01-18 | 2008-07-24 | Eli Lilly And Company | PEGYLATED Aβ FAB |
| CA2696996C (en) * | 2007-07-16 | 2016-03-22 | The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University | Antimicrobial constructs |
| CA2706425A1 (en) | 2007-11-27 | 2009-06-04 | Ablynx N.V. | Method for obtaining polypeptide constructs comprising two or more single domain antibodies |
| US8557965B2 (en) | 2008-04-07 | 2013-10-15 | Ablynx N.V. | Single variable domains against notch pathway members |
| KR20110016440A (ko) * | 2008-04-24 | 2011-02-17 | 셀틱 파르마 피이지 엘티디. | 연장된 반감기를 가진 제 ⅰⅹ 인자 접합체 |
| ES2560807T3 (es) * | 2008-07-21 | 2016-02-22 | Polytherics Limited | Nuevos reactivos y procedimiento de conjugación de moléculas biológicas |
| CN105646643A (zh) | 2008-10-29 | 2016-06-08 | 阿布林克斯公司 | 单域抗原结合性分子的纯化方法 |
| RU2481824C2 (ru) | 2008-10-29 | 2013-05-20 | Аблинкс Н.В | Препараты однодоменных антигенсвязывающих молекул |
| CA2747644C (en) | 2008-12-19 | 2023-01-24 | Ablynx N.V. | Method for generation of immunoglobulin sequences |
| MX2011010681A (es) | 2009-04-10 | 2012-01-20 | Ablynx Nv | Secuencias mejoradas de aminoacidos dirigidas contra il-6r y polipeptidos que comprenden el mismo para el tratamiento de enfermedades y trastornos relacionados con il-6r. |
| CN102459332B (zh) | 2009-06-05 | 2015-08-19 | 埃博灵克斯股份有限公司 | 用于预防和/或治疗呼吸道感染的单价、二价和三价抗人呼吸道合胞病毒(hrsv)纳米抗体构建体 |
| ES2804450T3 (es) | 2009-07-10 | 2021-02-08 | Ablynx Nv | Método para la producción de dominios variables |
| US8642737B2 (en) | 2010-07-26 | 2014-02-04 | Baxter International Inc. | Nucleophilic catalysts for oxime linkage |
| US8809501B2 (en) | 2009-07-27 | 2014-08-19 | Baxter International Inc. | Nucleophilic catalysts for oxime linkage |
| EP3081233B1 (de) | 2009-07-27 | 2020-12-23 | Baxalta GmbH | Glycopolysialylierung von proteinen ausser blutgerinnungsproteinen |
| BR112012001814A8 (pt) | 2009-07-27 | 2018-02-06 | Baxalta GmbH | Conjugados de proteína de coagulação sanguínea |
| RU2744370C2 (ru) | 2009-07-27 | 2021-03-05 | Баксалта Инкорпорейтед | Конъюгаты белков свертывания крови |
| UY32920A (es) | 2009-10-02 | 2011-04-29 | Boehringer Ingelheim Int | Moleculas de unión biespecíficas para la terapia anti-angiogénesis |
| UY32917A (es) | 2009-10-02 | 2011-04-29 | Boehringer Ingelheim Int | Moléculas de unión a dll-4 |
| US20130041134A1 (en) * | 2009-11-05 | 2013-02-14 | Sangart ,Inc. | Methods for preparing polyethylene glycol maleimide using n-(2-hydroxyethyl) maleimide as a starting material |
| WO2011064382A1 (en) | 2009-11-30 | 2011-06-03 | Ablynx N.V. | Improved amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections |
| HRP20251657T1 (hr) | 2009-12-14 | 2026-02-13 | Ablynx N.V. | Imunoglobulinska protutijela s jednostrukom varijabilnom domenom protiv ox40l, konstrukti i njihova terapijska upotreba |
| WO2011083140A1 (en) | 2010-01-08 | 2011-07-14 | Ablynx Nv | Immunoglobulin single variable domain directed against human cxcr4 |
| US9120855B2 (en) | 2010-02-10 | 2015-09-01 | Novartis Ag | Biologic compounds directed against death receptor 5 |
| PH12012501744A1 (en) | 2010-03-03 | 2021-08-09 | Boehringer Ingelheim Int | Biparatopic abeta binding polypeptides |
| EP2552962B1 (de) | 2010-03-26 | 2016-03-23 | Ablynx N.V. | Einzelne, gegen cxcr7 gerichtete variable immunoglobulindomänen |
| US9101674B2 (en) | 2010-03-29 | 2015-08-11 | Vib Vzw | Targeting and in vivo imaging of tumor-associated macrophages |
| US9556273B2 (en) | 2010-03-29 | 2017-01-31 | Vib Vzw | Anti-macrophage mannose receptor single variable domains for targeting and in vivo imaging of tumor-associated macrophages |
| GB201007356D0 (en) | 2010-04-30 | 2010-06-16 | Leverton Licence Holdings Ltd | Conjugated factor VIIa |
| JP2013533217A (ja) | 2010-05-17 | 2013-08-22 | セビックス・インコーポレイテッド | Ｐｅｇ化ｃ−ペプチド |
| US9932403B2 (en) | 2010-05-20 | 2018-04-03 | Ablynx Nv | Biological materials related to HER3 |
| AU2011277983C1 (en) | 2010-07-16 | 2016-09-29 | Ablynx Nv | Modified single domain antigen binding molecules and uses thereof |
| GB201014715D0 (en) | 2010-09-06 | 2010-10-20 | Vib Vzw | Nanobodies stabilizing functional conformational states of GPCRS |
| US20120225081A1 (en) | 2010-09-03 | 2012-09-06 | Boehringer Ingelheim International Gmbh | Vegf-binding molecules |
| PY1147875A (es) | 2010-11-08 | 2015-08-03 | Novartis Ag | Polipéptidos de enlace de los receptores de quimiocina |
| ES2800983T3 (es) | 2010-12-22 | 2021-01-07 | Baxalta GmbH | Materiales y métodos para conjugar un derivado de ácido graso soluble en agua con una proteína |
| US8440309B2 (en) | 2011-01-31 | 2013-05-14 | Confluent Surgical, Inc. | Crosslinked polymers with the crosslinker as therapeutic for sustained release |
| CN103533952B (zh) | 2011-03-15 | 2017-02-15 | 诺沃—诺迪斯克有限公司 | 包含半胱氨酸置换的人胰岛素类似物和衍生物 |
| AU2012234284B2 (en) | 2011-03-28 | 2015-10-08 | Ablynx Nv | Bispecific anti-CXCR7 immunoglobulin single variable domains |
| AU2012237287B2 (en) | 2011-03-30 | 2016-09-08 | Ablynx Nv | Methods of treating immune disorders with single domain antibodies against TNF-alpha |
| US20130078247A1 (en) | 2011-04-01 | 2013-03-28 | Boehringer Ingelheim International Gmbh | Bispecific binding molecules binding to dii4 and ang2 |
| US9527925B2 (en) | 2011-04-01 | 2016-12-27 | Boehringer Ingelheim International Gmbh | Bispecific binding molecules binding to VEGF and ANG2 |
| UA117218C2 (uk) | 2011-05-05 | 2018-07-10 | Мерк Патент Гмбх | Поліпептид, спрямований проти il-17a, il-17f та/або il17-a/f |
| US8815226B2 (en) | 2011-06-10 | 2014-08-26 | Mersana Therapeutics, Inc. | Protein-polymer-drug conjugates |
| EP2717916B1 (de) | 2011-06-10 | 2017-03-08 | Mersana Therapeutics, Inc. | Protein-polymer-wirkstoffkonjugate |
| US9695227B2 (en) | 2011-06-21 | 2017-07-04 | Vrije Universiteit Brussel | Binding domains directed against GPCR:G protein complexes and uses derived thereof |
| CN108610421B (zh) | 2012-02-27 | 2022-08-19 | 阿布林克斯有限公司 | Cx3cr1结合多肽 |
| US9328174B2 (en) | 2012-05-09 | 2016-05-03 | Novartis Ag | Chemokine receptor binding polypeptides |
| ES2715279T3 (es) | 2012-05-24 | 2019-06-03 | Vib Vzw | Dominios variables individuales inmunoglobulínicos anti-receptor de manosa de macrófagos para elegir como diana y obtener imágenes in vivo de macrófagos asociados a tumores |
| WO2014122183A1 (en) | 2013-02-05 | 2014-08-14 | Vib Vzw | Muscarinic acetylcholine receptor binding agents and uses thereof |
| US9617339B2 (en) | 2013-03-15 | 2017-04-11 | Vib Vzw | Method of imaging a cardiovascular disease with an anti-macrophage mannose receptor immunoglobulin single variable domain |
| CA2927022C (en) | 2013-10-11 | 2018-08-21 | Asana Biosciences, Llc | Protein-polymer-drug conjugates |
| WO2015054659A1 (en) | 2013-10-11 | 2015-04-16 | Mersana Therapeutics, Inc. | Protein-polymer-drug conjugates |
| CN103965357B (zh) | 2013-12-31 | 2016-08-17 | 嘉和生物药业有限公司 | 一种抗人rankl抗体 |
| WO2015121092A1 (en) | 2014-01-30 | 2015-08-20 | Vib Vzw | Opioid receptor binding agents and uses thereof |
| MA39711A (fr) * | 2014-04-03 | 2015-10-08 | Nektar Therapeutics | Conjugués d'une fraction d'il-15 et d'un polymère |
| NL2013661B1 (en) | 2014-10-21 | 2016-10-05 | Ablynx Nv | KV1.3 Binding immunoglobulins. |
| ES2885854T3 (es) | 2014-10-14 | 2021-12-15 | Polytherics Ltd | Proceso para la conjugación de un péptido o proteína con un reactivo que comprende un grupo saliente que incluye una porción de PEG |
| EP3085709B1 (de) | 2014-12-28 | 2019-08-21 | Genor Biopharma Co., Ltd | Humanisierte antikörper gegen menschliches rankl, pharmazeutische zusammensetzung und verwendung davon |
| WO2017062832A1 (en) | 2015-10-08 | 2017-04-13 | Nektar Therapeutics | Combination of an il-2rbeta-selective agonist and a long-acting il-15 agonist |
| CN109071632B (zh) | 2016-02-05 | 2022-12-30 | 奥里尼斯生物科学私人有限公司 | 靶向性治疗剂及其用途 |
| US11248057B2 (en) | 2016-03-07 | 2022-02-15 | Vib Vzw | CD20 binding single domain antibodies |
| WO2017158436A1 (en) | 2016-03-17 | 2017-09-21 | Oslo Universitetssykehus Hf | Fusion proteins targeting tumour associated macrophages for treating cancer |
| SG11201808528VA (en) | 2016-03-30 | 2018-10-30 | Convatec Technologies Inc | Modified wound dressings |
| CN109152845B (zh) | 2016-04-14 | 2022-07-12 | 宝力泰锐克斯有限公司 | 含有在环内包含至少两个(-ch2-ch2-o-)单元的接头的缀合物和缀合试剂 |
| EP3455245A2 (de) | 2016-05-13 | 2019-03-20 | Orionis Biosciences NV | Therapeutisches targeting von nichtzellulären strukturen |
| GB201608936D0 (en) | 2016-05-20 | 2016-07-06 | Polytherics Ltd | Novel conjugates and novel conjugating reagents |
| GB201615725D0 (en) | 2016-09-15 | 2016-11-02 | Polytherics Ltd | Novel cytotoxic agents and conjugates thereof |
| US11840569B2 (en) | 2016-11-16 | 2023-12-12 | Ablynx N.V. | T cell recruiting polypeptides capable of binding CD123 and TCR alpha/beta |
| KR102642385B1 (ko) | 2017-02-06 | 2024-03-04 | 오리오니스 바이오사이언시스 엔브이 | 표적화된 키메라 단백질 및 이의 용도 |
| EP3576765B1 (de) | 2017-02-06 | 2025-07-16 | Orionis Biosciences, Inc. | Zielgerichtetes manipuliertes interferon und verwendungen davon |
| KR20250057110A (ko) | 2017-05-15 | 2025-04-28 | 넥타르 테라퓨틱스 | 지속 작용성 인터류킨-15 수용체 효현제 및 관련 면역요법 조성물 및 방법 |
| CN110997001A (zh) | 2017-06-02 | 2020-04-10 | 默克专利股份有限公司 | Mmp13结合免疫球蛋白 |
| IL270951B2 (en) | 2017-06-02 | 2025-05-01 | Merck Patent Gmbh | ADAMTS5, MMP13 and aggrecan-binding polypeptides |
| CN118085076A (zh) | 2017-06-02 | 2024-05-28 | 埃博灵克斯股份有限公司 | 结合聚集蛋白聚糖的免疫球蛋白 |
| US11261260B2 (en) | 2017-06-02 | 2022-03-01 | Merck Patent Gmbh | ADAMTS binding immunoglobulins |
| EP4635987A3 (de) | 2017-10-31 | 2026-01-14 | Vib Vzw | Neue antigenbindende chimäre proteine sowie verfahren und verwendungen davon |
| US12655186B2 (en) | 2018-01-26 | 2026-06-16 | Orionis Biosciences, Inc. | Chimeric protein comprising anti-XCR1 antibody and modified interferon alpha 2 |
| CA3090406A1 (en) | 2018-02-05 | 2019-08-08 | Orionis Biosciences, Inc. | Fibroblast binding agents and use thereof |
| WO2020198665A1 (en) | 2019-03-28 | 2020-10-01 | Orionis Biosciences, Inc. | Fibroblast activation protein binding agents and use thereof |
| EP4294834A2 (de) | 2021-02-19 | 2023-12-27 | The United States of America, as represented by The Secretary, Department of Health and Human Services | Einzeldomänenantikörper zur neutralisierung von sars-cov-2 |
| US20260103529A1 (en) | 2022-10-18 | 2026-04-16 | Confo Therapeutics N.V. | Amino Acid Sequences Directed Against the Melanocortin 4 Receptor and Polypeptides Comprising the Same for the Treatment of MC4R-Related Diseases and Disorders |
| US20240415974A1 (en) | 2022-12-23 | 2024-12-19 | Ablynx N.V. | Protein-based conjugation carriers |
| CN122438859A (zh) | 2023-12-22 | 2026-07-21 | 阿布林克斯有限公司 | 用于核内递送的基于蛋白质的缀合载体 |
| US20250236673A1 (en) | 2023-12-22 | 2025-07-24 | Ablynx N.V. | Protein-based carriers for site-specific amine conjugation |
Family Cites Families (117)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2206317A1 (en) | 1972-11-16 | 1974-06-07 | Inst Francais Du Petrole | Coating compsn prepd. from a polyhydroxy cpd. - by (trans)esterification with a maleimido-benzoic acid deriv |
| US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| JPS5821649B2 (ja) | 1974-02-13 | 1983-05-02 | 古河電気工業株式会社 | フホウワポリエステルケイジユシノ セイゾウホウホウ |
| US4288612A (en) * | 1976-06-21 | 1981-09-08 | Chevron Research Company | Deposit control additives |
| US4179551A (en) * | 1977-10-25 | 1979-12-18 | Trw, Inc. | Low temperature curable compliant bismaleimide compositions |
| US4229550A (en) * | 1978-12-11 | 1980-10-21 | Trw Inc. | Flexibilized vinyl polybutadiene maleimide resins |
| GB2047418B (en) * | 1979-01-25 | 1983-02-23 | Fuji Photo Film Co Ltd | Silver halide photographic materials |
| JPS57192418A (en) | 1981-05-21 | 1982-11-26 | Mitsui Toatsu Chem Inc | Curable resin composition |
| JPS57205413A (en) | 1981-06-11 | 1982-12-16 | Mitsui Toatsu Chem Inc | Curable resin composition |
| JPS5815515A (ja) | 1981-07-21 | 1983-01-28 | Mitsui Toatsu Chem Inc | 熱硬化性樹脂組成物 |
| JPS5840374A (ja) | 1981-09-04 | 1983-03-09 | Mitsui Toatsu Chem Inc | 防汚塗料 |
| JPS60156395A (ja) * | 1984-01-17 | 1985-08-16 | Mihama Hisaharu | 修飾リパーゼ |
| US4675414A (en) * | 1985-03-08 | 1987-06-23 | The United States Of America As Represented By The Secretary Of The Navy | Maleimidomethyl-carbonate polyethers |
| US4839345A (en) * | 1985-03-09 | 1989-06-13 | Nippon Oil And Fats Co., Ltd. | Hydrated adhesive gel and method for preparing the same |
| JPS6328645A (ja) | 1986-07-23 | 1988-02-06 | 東レ株式会社 | 積層フイルム |
| JPS63277619A (ja) | 1987-05-11 | 1988-11-15 | Nippon Oil & Fats Co Ltd | シ−ト状貼着剤の製造方法 |
| JPS6462338A (en) | 1987-09-02 | 1989-03-08 | Bridgestone Corp | Rubber composition |
| JPS6488129A (en) | 1987-09-29 | 1989-04-03 | Nippon Oils & Fats Co Ltd | Sheet-like detecting material for inspecting leakage |
| EP0318162A3 (de) * | 1987-11-25 | 1990-11-07 | Texaco Development Corporation | Bismaleinimid-Derivate |
| EP0357110A1 (de) | 1988-08-05 | 1990-03-07 | Akzo N.V. | Zwei-Komponenten-Anstrichmasse, härtbar bei Zimmertemperatur durch eine Diels-Alder-Reaktion |
| JPH02149335A (ja) | 1988-11-30 | 1990-06-07 | Nippon Oil & Fats Co Ltd | キトサン・ゼラチン架橋ゲル |
| US5166322A (en) * | 1989-04-21 | 1992-11-24 | Genetics Institute | Cysteine added variants of interleukin-3 and chemical modifications thereof |
| US5620689A (en) * | 1989-10-20 | 1997-04-15 | Sequus Pharmaceuuticals, Inc. | Liposomes for treatment of B-cell and T-cell disorders |
| US5527528A (en) * | 1989-10-20 | 1996-06-18 | Sequus Pharmaceuticals, Inc. | Solid-tumor treatment method |
| US6552170B1 (en) * | 1990-04-06 | 2003-04-22 | Amgen Inc. | PEGylation reagents and compounds formed therewith |
| US5766897A (en) * | 1990-06-21 | 1998-06-16 | Incyte Pharmaceuticals, Inc. | Cysteine-pegylated proteins |
| AU1674292A (en) | 1991-03-15 | 1992-10-21 | Synergen, Inc. | Pegylation of polypeptides |
| US6326353B1 (en) | 1993-03-23 | 2001-12-04 | Sequus Pharmaceuticals, Inc. | Enhanced circulation effector composition and method |
| AU6368394A (en) | 1993-03-23 | 1994-10-11 | Liposome Technology, Inc. | Polymer-polypeptide composition and method |
| US6180134B1 (en) * | 1993-03-23 | 2001-01-30 | Sequus Pharmaceuticals, Inc. | Enhanced ciruclation effector composition and method |
| FR2706900B1 (de) * | 1993-06-25 | 1995-09-08 | Flamel Tech Sa | |
| GB9317618D0 (en) | 1993-08-24 | 1993-10-06 | Royal Free Hosp School Med | Polymer modifications |
| JPH09504174A (ja) | 1993-10-29 | 1997-04-28 | インサイト ファーマシューティカルズ，インク． | プロテアーゼネキシン１変異体を含むキメラ蛋白 |
| JPH07132685A (ja) | 1993-11-11 | 1995-05-23 | Fuji Photo Film Co Ltd | 熱転写材料 |
| CN1110681A (zh) | 1994-04-20 | 1995-10-25 | 中国科学院上海生物化学研究所 | 一种新型的蛋白质及多肽巯基聚乙二醇(peg)化试剂 |
| US5583114A (en) * | 1994-07-27 | 1996-12-10 | Minnesota Mining And Manufacturing Company | Adhesive sealant composition |
| JP3399100B2 (ja) | 1994-07-27 | 2003-04-21 | 日本油脂株式会社 | オキシアルキレン誘導体 |
| JP3525516B2 (ja) | 1994-10-27 | 2004-05-10 | 日本油脂株式会社 | 反応性小胞体、小胞体修飾剤および製造方法 |
| US5997861A (en) | 1994-10-31 | 1999-12-07 | Burstein Laboratories, Inc. | Antiviral supramolecules containing target-binding molecules and therapeutic molecules bound to spectrin |
| ZA959606B (en) * | 1994-11-15 | 1996-05-29 | Shell Int Research | A cross-linked resin |
| US5932462A (en) * | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
| US5585484A (en) * | 1995-04-19 | 1996-12-17 | Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University | Hemoglobin crosslinkers |
| US6521211B1 (en) | 1995-06-07 | 2003-02-18 | Bristol-Myers Squibb Medical Imaging, Inc. | Methods of imaging and treatment with targeted compositions |
| US6139819A (en) | 1995-06-07 | 2000-10-31 | Imarx Pharmaceutical Corp. | Targeted contrast agents for diagnostic and therapeutic use |
| CA2218541A1 (en) | 1995-06-07 | 1996-12-19 | Imarx Pharmaceutical Corp. | Novel targeted compositions for diagnostic and therapeutic use |
| WO1998002743A1 (en) | 1996-07-15 | 1998-01-22 | Sensors Technology Company B.V. | Sensors |
| US6271339B1 (en) * | 1996-09-12 | 2001-08-07 | Sartomer Company, Inc. | Prepolymers having maleimide functions the process for preparing them and their uses |
| US6306923B1 (en) * | 1996-09-12 | 2001-10-23 | Sartomer Company, Inc. | Ultraviolet or visible light polymerizable and/or crosslinkable maleimide-functional coating compositions |
| AU4373297A (en) | 1996-09-19 | 1998-04-14 | Diagnocure Inc. | Polyethyleneglycol conjugated nanoerythrosomes, method of making same and use thereof |
| US6261537B1 (en) * | 1996-10-28 | 2001-07-17 | Nycomed Imaging As | Diagnostic/therapeutic agents having microbubbles coupled to one or more vectors |
| CA2269985A1 (en) | 1996-10-28 | 1998-05-07 | Aslak Godal | Improvements in or relating to diagnostic/therapeutic agents |
| US6331289B1 (en) * | 1996-10-28 | 2001-12-18 | Nycomed Imaging As | Targeted diagnostic/therapeutic agents having more than one different vectors |
| US6210707B1 (en) * | 1996-11-12 | 2001-04-03 | The Regents Of The University Of California | Methods of forming protein-linked lipidic microparticles, and compositions thereof |
| AU5451598A (en) | 1996-11-22 | 1998-06-10 | Regents Of The University Of California, The | Transport of liposomes across the blood-brain barrier |
| DE19652544A1 (de) | 1996-12-17 | 1998-06-18 | Wacker Chemie Gmbh | Härtbare Organosiloxanmassen |
| EP2319854B1 (de) | 1997-01-08 | 2016-11-30 | Sigma-Aldrich Co. LLC | Biokonjugation von Makromolekülen |
| DK1007082T3 (da) | 1997-01-15 | 2007-02-19 | Phoenix Pharmacologics Inc | Modificeret tumor nekrose faktor |
| US5844020A (en) * | 1997-03-31 | 1998-12-01 | Xerox Corporation | Phase change ink compositions |
| US7452551B1 (en) | 2000-10-30 | 2008-11-18 | Imarx Therapeutics, Inc. | Targeted compositions for diagnostic and therapeutic use |
| US6183738B1 (en) * | 1997-05-12 | 2001-02-06 | Phoenix Pharamacologics, Inc. | Modified arginine deiminase |
| JP3599160B2 (ja) | 1997-05-16 | 2004-12-08 | 大日本インキ化学工業株式会社 | マレイミド誘導体を含有する活性エネルギー線硬化性組成物及び該活性エネルギー線硬化性組成物の硬化方法 |
| ATE375363T1 (de) | 1997-07-14 | 2007-10-15 | Bolder Biotechnology Inc | Derivate des wachstumshormons und verwandte proteine |
| US6495136B1 (en) | 1998-03-26 | 2002-12-17 | The Procter & Gamble Company | Proteases having modified amino acid sequences conjugated to addition moieties |
| BR9815774A (pt) | 1998-03-26 | 2000-11-14 | Sun Chemical Corp | Composições curáveis por energia compatìveis com água contendo derivados de maleimida; revestimento ou tinta de impressão e método para curar tais composições. |
| JPH11349877A (ja) | 1998-04-23 | 1999-12-21 | Tektronix Inc | 相変化インク・キャリア組成物 |
| WO1999055837A2 (en) | 1998-04-28 | 1999-11-04 | Nycomed Imaging As | Improvements in or relating to separation processes |
| GB9812545D0 (en) | 1998-06-10 | 1998-08-05 | Celltech Therapeutics Ltd | Biological products |
| EP1097378A2 (de) | 1998-07-21 | 2001-05-09 | Burstein Laboratories Inc. | Optische platten-testvorrichtung und verfahren |
| WO2000010974A2 (en) | 1998-08-20 | 2000-03-02 | Dsm N.V. | Process for the preparation of a maleimide compound, maleimide compound, radiation-curable compositions comprising said compound and coated products |
| AU743363B2 (en) | 1998-09-22 | 2002-01-24 | Procter & Gamble Company, The | Personal care compositions containing active proteins tethered to a water insoluble substrate |
| ES2257094T3 (es) | 1998-11-03 | 2006-07-16 | Centocor, Inc. | Anticuerpos modificados y fragmentos de anticuerpo con duracion de actividad aumentada. |
| JP2000144041A (ja) | 1998-11-13 | 2000-05-26 | Dainippon Ink & Chem Inc | マレイミド誘導体を含有する木質材表面被覆用活性エネルギー線硬化性組成物及び該組成物の硬化方法 |
| JP4214579B2 (ja) | 1998-11-13 | 2009-01-28 | Ｄｉｃ株式会社 | マレイミド誘導体を含有する活性エネルギー線硬化性インキ及び該硬化性インキの硬化方法 |
| JP4113978B2 (ja) | 1998-11-17 | 2008-07-09 | Ｄｉｃ株式会社 | マレイミド誘導体を含有する活性エネルギー線硬化性樹脂組成物 |
| JP2000191700A (ja) * | 1998-12-28 | 2000-07-11 | Kyowa Hakko Kogyo Co Ltd | 持続型消化管運動ペプチド |
| EP1046394A3 (de) | 1999-04-19 | 2001-10-10 | ImaRx Pharmaceutical Corp. | Neue Zusammensetzungen zur Verwendung bei der Verabreichung von Verbindungen in das Zellinnere |
| JP2000306605A (ja) | 1999-04-22 | 2000-11-02 | Dainippon Ink & Chem Inc | 活性エネルギー線硬化性高分子固体電解質およびその製造方法 |
| JP2000319252A (ja) | 1999-05-10 | 2000-11-21 | Dainippon Ink & Chem Inc | マレイミド誘導体の製造方法 |
| MXPA02000842A (es) * | 1999-07-22 | 2002-07-30 | Procter & Gamble | Conjugados de proteasa que tienen sitios de corte protegidos estericamente. |
| WO2001007577A2 (en) | 1999-07-22 | 2001-02-01 | The Procter & Gamble Company | Protease conjugates having sterically protected epitope regions |
| GB9919338D0 (en) | 1999-08-16 | 1999-10-20 | Celltech Therapeutics Ltd | Biological products |
| US6303119B1 (en) * | 1999-09-22 | 2001-10-16 | The Procter & Gamble Company | Personal care compositions containing subtilisin enzymes bound to water insoluble substrates |
| US7220401B2 (en) * | 1999-09-24 | 2007-05-22 | Barnes-Jewish Hospital | Blood clot-targeted nanoparticles |
| US6180598B1 (en) * | 1999-10-07 | 2001-01-30 | Deanna J. Nelson | Covalently modified hemoglobin having low temperature-dependent oxygen-binding function |
| JP2001172554A (ja) | 1999-12-21 | 2001-06-26 | Dainippon Ink & Chem Inc | マレイミド誘導体を含有する活性エネルギー線硬化性金属被覆組成物 |
| US7691367B2 (en) * | 1999-12-24 | 2010-04-06 | Kyowa Hakko Kirin Co., Ltd. | Branched polyalkylene glycols |
| US6602498B2 (en) * | 2000-02-22 | 2003-08-05 | Shearwater Corporation | N-maleimidyl polymer derivatives |
| JP4701497B2 (ja) | 2000-03-07 | 2011-06-15 | Ｄｉｃ株式会社 | マレイミド誘導体の製造方法 |
| JP2001294777A (ja) | 2000-04-14 | 2001-10-23 | Dainippon Ink & Chem Inc | グラフト化顔料およびその製造方法 |
| JP2002121221A (ja) | 2000-08-09 | 2002-04-23 | Dainippon Ink & Chem Inc | 光硬化性着色組成物 |
| EP1321930A4 (de) | 2000-09-19 | 2006-08-02 | Dainippon Ink & Chemicals | Aufzeichnungs/wiedergabe verfahren unter verwendung der blau-violett laserlicht und dafür geeignetes informationsaufzeichnungsmediums |
| KR20030063362A (ko) | 2000-10-20 | 2003-07-28 | 다이니뽄 잉끼 가가꾸 고오교오 가부시끼가이샤 | 고분자 고체 전해질 및 그 전해질을 사용한 전지 |
| JP2004513576A (ja) | 2000-10-30 | 2004-04-30 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | エンハンスされる番組コンテンツをユーザの嗜好に合わせて自動的にカスタマイズする適応方法及び適応装置 |
| TW593427B (en) * | 2000-12-18 | 2004-06-21 | Nektar Therapeutics Al Corp | Synthesis of high molecular weight non-peptidic polymer derivatives |
| CA2436623C (en) | 2001-01-30 | 2011-08-02 | Kyowa Hakko Kogyo Co., Ltd. | Branched polyalkylene glycols |
| JP4756296B2 (ja) | 2001-03-14 | 2011-08-24 | Ｄｉｃ株式会社 | マレイミド誘導体及びそれを用いた光配向膜の製造方法 |
| JP4803412B2 (ja) | 2001-03-14 | 2011-10-26 | Ｄｉｃ株式会社 | マレイミド誘導体を含有する光配向材料及び光配向膜の製造方法 |
| HUP0303616A3 (en) | 2001-03-26 | 2006-07-28 | Alza Corp Mountain View | Liposome composition for improved intracellular delivery of a therapeutic agent |
| US6774116B2 (en) | 2001-04-17 | 2004-08-10 | Cryolife, Inc. | Prodrugs via acylation with cinnamate |
| CA2488850A1 (en) | 2001-06-08 | 2002-12-19 | Mandalmed, Inc. | Sustained release n-terminally truncated galectin-3 and antibodies to galectin-3 carbohydrate ligands for use in treating cancer |
| WO2003000278A1 (en) * | 2001-06-22 | 2003-01-03 | Kyowa Hakko Kogyo Co., Ltd. | Ointments |
| JP2003040939A (ja) | 2001-07-26 | 2003-02-13 | Dainippon Ink & Chem Inc | 活性エネルギー線硬化性樹脂組成物 |
| JP4123856B2 (ja) * | 2001-07-31 | 2008-07-23 | 日油株式会社 | 生体関連物質の修飾剤およびポリオキシアルキレン誘導体の製造方法 |
| AU2002330139A1 (en) | 2001-10-03 | 2003-04-14 | Vanderbilt University | In vivo panning for ligands to radiation-induced molecules |
| US7138370B2 (en) | 2001-10-11 | 2006-11-21 | Amgen Inc. | Specific binding agents of human angiopoietin-2 |
| AU2002337954C1 (en) | 2001-10-22 | 2008-10-23 | The Scripps Research Institute | Integrin targeting compounds |
| US20030149307A1 (en) * | 2001-10-24 | 2003-08-07 | Baxter International Inc. | Process for the preparation of polyethylene glycol bis amine |
| GB0129121D0 (en) | 2001-12-05 | 2002-01-23 | Ic Vec Ltd | Compound |
| US20030153491A1 (en) * | 2002-01-11 | 2003-08-14 | Winslow Robert M. | Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin |
| PT3025726T (pt) | 2002-01-18 | 2020-01-09 | Biogen Ma Inc | Compostos do polímero polialquileno e utilizações dos mesmos |
| JP4587631B2 (ja) | 2002-01-30 | 2010-11-24 | Ｄｉｃ株式会社 | 熱硬化性樹脂組成物 |
| US20050148763A1 (en) | 2002-02-01 | 2005-07-07 | Chugai Seiyaku Kabushiki Kaisha | Peg-binding pth or peg-binding pth derivative |
| JP2003241337A (ja) | 2002-02-18 | 2003-08-27 | Konica Corp | 光熱写真画像形成材料 |
| US6815078B2 (en) * | 2002-03-06 | 2004-11-09 | Eastman Kodak Company | Substrate for protein microarray containing functionalized polymer |
| KR101031206B1 (ko) * | 2002-12-31 | 2011-04-27 | 넥타르 테라퓨틱스 | 말레암산 중합체 유도체 및 이의 바이오컨쥬게이트 |
| US7910661B2 (en) * | 2003-01-06 | 2011-03-22 | Nektar Therapeutics | Thiol-selective water-soluble polymer derivatives |
| EP1725262B1 (de) * | 2004-03-15 | 2021-05-26 | Nektar Therapeutics | Polymerische Zusammensetzungen und Konjugate von HIV-Entry-Inhibitoren |
-
2003
- 2003-12-31 AT AT03800391T patent/ATE444984T1/de not_active IP Right Cessation
- 2003-12-31 WO PCT/US2003/041699 patent/WO2004060965A2/en not_active Ceased
- 2003-12-31 US US10/751,274 patent/US7432330B2/en not_active Expired - Lifetime
- 2003-12-31 MX MXPA05007151A patent/MXPA05007151A/es active IP Right Grant
- 2003-12-31 AU AU2003300133A patent/AU2003300133B2/en not_active Expired
- 2003-12-31 CN CNB2003801080107A patent/CN100343304C/zh not_active Expired - Lifetime
- 2003-12-31 CA CA2509153A patent/CA2509153C/en not_active Expired - Lifetime
- 2003-12-31 DE DE60329627T patent/DE60329627D1/de not_active Expired - Lifetime
- 2003-12-31 JP JP2004564914A patent/JP4490290B2/ja not_active Expired - Lifetime
- 2003-12-31 EP EP03800391A patent/EP1578842B1/de not_active Expired - Lifetime
- 2003-12-31 KR KR1020057012482A patent/KR101025143B1/ko not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004060965A2 (en) | 2004-07-22 |
| CA2509153C (en) | 2013-04-16 |
| JP2006512445A (ja) | 2006-04-13 |
| AU2003300133A1 (en) | 2004-07-29 |
| CA2509153A1 (en) | 2004-07-22 |
| US20040204548A1 (en) | 2004-10-14 |
| EP1578842A2 (de) | 2005-09-28 |
| MXPA05007151A (es) | 2005-09-21 |
| KR101025143B1 (ko) | 2011-04-01 |
| JP4490290B2 (ja) | 2010-06-23 |
| EP1578842B1 (de) | 2009-10-07 |
| CN100343304C (zh) | 2007-10-17 |
| WO2004060965A3 (en) | 2004-10-07 |
| AU2003300133B2 (en) | 2008-11-13 |
| DE60329627D1 (de) | 2009-11-19 |
| US7432330B2 (en) | 2008-10-07 |
| CN1732206A (zh) | 2006-02-08 |
| KR20050098852A (ko) | 2005-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60329627D1 (de) | Hydrolysestabile maleimidendgruppen-enthaltende polymere | |
| AU2003225295A1 (en) | Substituted pyrroline kinase inhibitors | |
| LT1935427T (lt) | Tirpaus ctla4 mutantinių molekulių panaudojimas | |
| AU2003240517A1 (en) | Substituted pyrrolines as kinase inhibitors | |
| PT1189970E (pt) | Aditivo carboxi-funcional para a condensacao de poliamidas | |
| DE50304702D1 (de) | Verfahren zur Herstellung hochreaktiver Polyisobutene | |
| PL1682530T3 (pl) | Podstawione pirolo-indole jako inhibitory PAI-1 | |
| DK1362047T3 (da) | Indazolylsubstituerede pyrrolinforbindelser som kinaseinhibitorer | |
| AU2002320317A1 (en) | Novel mesogens and methods for their synthesis and use | |
| DE60128159D1 (de) | Vorrichtung zur reformierung von Brennstoff | |
| DE60306920D1 (de) | Vorrichtung zur bestimmung der feinheit von mineralfasern | |
| MY130718A (en) | Antitumor compounds and methods | |
| DE69821783D1 (de) | Polymere verbindungen von camptothecin | |
| DE50109023D1 (de) | Vorrichtung zur Herstellung von Wellrohren | |
| AU2889201A (en) | Automatic water toxicity measuring apparatus | |
| DE69935499D1 (de) | Verbessertes polymer-gemisch zur entwässerung | |
| WO2005009928A3 (en) | Preparation and use of alkylating agents | |
| DE102005053064A1 (de) | Verfahren zur Herstellung von Pfropfpolymerisaten | |
| IL162052A (en) | Indole compounds that inhibit phospholipase a2 cytosolic, methods for their preparation and uses | |
| NO20035380D0 (no) | Fremgangsmåte for dannelse av m degree nster | |
| DE60330099D1 (de) | Verfahren und Anordnungen zur Herstellung, Feststellung und Übertragung von Identifikatoren | |
| EP1672761A4 (de) | Polymer-muffe und kabelabschluss-endverbinder damit | |
| DE60115971D1 (de) | Verfahren zur Herstellung von Cellulosepolymeren | |
| DE60127131D1 (de) | Tricyclische imidazopyridine | |
| DE69915486D1 (de) | Verwendung von eletriptan zur vorbeugung des wiederauftretens der migräne |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |